ORI CAPITAL
ORI Healthcare Fund L.P. is a US$200 million venture capital fund focused on investing in innovative companies with disruptive technologies in the healthcare industry globally. The fund is founded by Ms. Simone Song, former investment banker and head of China Healthcare at Goldman Sachs. The team consists mostly of former Goldman Sachs bankers and healthcare scientists. The Fund is supported by a network of most renowned scientists, practitioners and entrepreneurs.
ORI CAPITAL
Industry:
Health Care
Founded:
2015-01-01
Status:
Active
Contact:
+852 3898 1500
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Apache Organization Schema JsDelivr Cloudflare JS CDN JS
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-07 | AffyImmune Therapeutics | ORI Capital investment in Series A - AffyImmune Therapeutics | 20 M USD |
| 2020-12-10 | CG Oncology | ORI Capital investment in Series D - CG Oncology | 47 M USD |
| 2020-05-12 | Pillar Biosciences | ORI Capital investment in Series C - Pillar Biosciences | 29.7 M USD |
| 2019-03-18 | CG Oncology | ORI Capital investment in Series C - CG Oncology | 22 M USD |
| 2018-10-25 | Enable Injections | ORI Capital investment in Series B - Enable Injections | 50 M USD |
| 2017-12-20 | Orchard Therapeutics | ORI Capital investment in Series B - Orchard Therapeutics | 110 M USD |
| 2017-11-29 | Semma Therapeutics | ORI Capital investment in Series B - Semma Therapeutics | 114 M USD |
| 2017-11-15 | Arterys | ORI Capital investment in Series B - Arterys | 30 M USD |
| 2017-03-03 | TriSalus Life Sciences | ORI Capital investment in Series D - TriSalus Life Sciences | 12.8 M USD |
| 2016-11-24 | Kymab | ORI Capital investment in Series C - Kymab | 100 M USD |
More informations about "ORI Capital"
Home - ORI Capital
ORI Capital. ORI Capital is a venture capital firm founded in 2015. Our Funds invest in innovative early-stage biotech companies globally, in the areas of diagnostics, drug delivery, and …See details»
ORI Capital - Crunchbase Investor Profile & Investments
ORI Fund is a venture capital fund that invests in innovative companies with disruptive technologies in the global healthcare industry. The fund is founded by Ms. Simone Song, former investment banker and head of China Healthcare at …See details»
Our Team - ORI Capital
Meet the ORI Capital team, a group of professionals dedicated to investing in life-saving scientific advancements.See details»
About Us - ORI Capital
Our mission is to be both financially successful for our investors and socially impactful to patients worldwide.See details»
ORI Capital - Investments, Portfolio & Company Exits - Crunchbase
ORI Capital 's most notable exits include TriSalus Life Sciences, CG Oncology, and Semma Therapeutics. Which industries has this organization had the most exits in? Show . TriSalus …See details»
ORI Capital Raises $260 Million for Second Life …
Feb 22, 2024 The ORI Capital investment team brings decades of experience investing in the biotech and healthcare sector and will leverage the expansive resources of the firm’s proprietary big data and AI ...See details»
'Golden era of innovation': ORI Capital raises $260M …
Feb 22, 2024 ORI Capital has raised a $260 million life sciences fund that will go toward early-stage biotechs worldwide. ORI Capital has raised $260 million, the venture capital firm’s second life sciences ...See details»
ORI Capital - Funding, Financials, Valuation & Investors - Crunchbase
ORI Capital has raised a total of $660M across 2 funds, their latest being ORI Fund II. This fund was announced on Feb 22, 2024 and raised a total of . $260M. Announced Date . Fund Name …See details»
ORI Capital Concludes Second Fund ORI Fund II with $260 Million …
Feb 22, 2024 ORI Capital has successfully closed its second fund, ORI Fund II, with total commitments of $260 million, meeting the fund's original target. Led by Simone Song, the firm …See details»
ORI Capital Raises $260 Million for Second Life Sciences Fund
Feb 22, 2024 HONG KONG& NATICK, Mass.---- ORI Capital today announced the final close of its second fund, ORI Fund II, with total commitments of $260 million. Founded in 2015, and led …See details»
ORI Capital investment portfolio - PitchBook
ORI Capital's latest investment was on 01-Oct-2022 in CG Oncology, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate …See details»
ORI Capital, the venture firm behind CG’s big IPO, raises new …
Feb 22, 2024 ORI Capital, the China- and U.S.-based venture investor behind the biotechnology sector’s largest initial public offering this year, has raised a new life sciences fund, the firm …See details»
ORI Capital wraps up sophomore life sciences fund at $260m
Feb 23, 2024 ORI Capital, a biotech investor based in Hong Kong, has closed its second fund at $260 million. “We are in a golden-era of innovation across the intersection of AI and biology, …See details»
ORI Capital Collects $260 Million for Second Life-Sciences Venture …
Feb 22, 2024 Photo: ORI Capital. ORI Capital, a life-sciences venture firm launched following a health scare its founder suffered, has raised a $260 million second fund after making several …See details»
Ori Capital hits first close on targeted $400m fund - Tech in Asia
Jan 13, 2021 A spokeswoman for the company said that Ori Capital has already reached the first close of the fund, gaining US$112 million in support. The final completion is expected to be …See details»
ORI Capital exits investment in Kymab to Sanofi in a $1.1B
Jan 14, 2021 Hong Kong-based healthcare fund management firm ORI Capital has decided to exit Kymab, a British biopharmaceutical company that specializes in vaccines and novel drug …See details»
PE Spotlight: ORI Capital secures USD 232m for Fund II ahead of …
ORI Fund I co-led Kymab’s Series C Preferred Shares nancing round with Hepalink. Pharmaceutical [HKSE:9989, SHE:002399] in November 2016. ORI Fund I also made follow …See details»
Healthcare-focused ORI Capital targets $400 mln in new fund
HONG KONG, Jan 12 (Reuters) - Hong Kong-based ORI Capital, an investment firm focusing on the healthcare sector, said on Tuesday it is targeting $400 million in a new fund. ORI Capital …See details»
Simone Song’s ORI Capital closes $260M second fund after CG …
Feb 22, 2024 Simone Song, ORI Capital founding partner. February 22, 2024 08:00 AM EST. Financing. Startups. Simone Song's ORI Capital closes $260M second fund after CG …See details»
Our Advisors - ORI Capital
A prominent and influential advisory team significantly engaged throughout ORI Capital’s investment cycle. Jack Szostak, PhD. Dr. Szostak is a 2009 Nobel Prize Laureate in …See details»